EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies

Franck Maizaud iD, Selim Arraki-Zava, Hamza Sayadi, Yeleen Fromage iD, Pierre Marquet, Jean-Baptiste Woillard iD, Caroline Monchaud iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0330854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Franck Maizaud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France. Hauptthemen laut MEDLINE: Mycophenolic Acid, Immunosuppressive Agents, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Missed doses of mycophenolate mofetil (MMF) are frequent in transplant recipients and may lead to subtherapeutic exposure to mycophenolic acid (MPA), potentially compromising graft function. However, current guidance on how to manage such deviations remains empirical and is not supported by pharmacokinetic evidence.

Methods

We used two validated population pharmacokinetic models of MPA to simulate steady-state exposure in virtual cohorts of renal transplant recipients treated with MMF. Scenarios included full missed doses, delays in intake (2–10 hours), and compensation strategies (50% or 100% added at the next dose). Simulations were performed for six dose regimens (500–1250 mg BID) and analyzed in terms of AUC 0–12h , proportion of patients outside the target range (30–60 mg·h/L), and time to return to steady state.

Results

A fully missed dose resulted in a 40–60% reduction in AUC 0–12h , with delayed return to steady state (up to 72 hours). Delays ≤6 hours caused minimal impact (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycophenolic AcidImmunosuppressive AgentsModels, BiologicalHumansKidney TransplantationArea Under CurveComputer SimulationFemaleDose-Response Relationship, DrugMaleMiddle Aged

Substanzen

Mycophenolic AcidImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.
  • INSERM UMR-1248 "Pharmacology & Transplantation", Limoges, France.
  • Fédération Hospitalo-Universitaire "Survival Optimization in Organ Transplantation" (FHU SUPORT), Limoges, France.

ORCID-Profile: Franck Maizaud, Yeleen Fromage, Jean-Baptiste Woillard, Caroline Monchaud

Zitieren

APA

Maizaud, F., Arraki-Zava, S., Sayadi, H., Fromage, Y., Marquet, P., Woillard, J. B., & Monchaud, C. (2025). Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies. PLOS One. https://doi.org/10.1371/journal.pone.0330854

Vancouver

Maizaud F, Arraki-Zava S, Sayadi H, Fromage Y, Marquet P, Woillard JB, et al. Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies. PLOS One. 2025. doi:10.1371/journal.pone.0330854

BibTeX
@article{Maizaud2025,
  author = {Maizaud, Franck and Arraki-Zava, Selim and Sayadi, Hamza and Fromage, Yeleen and Marquet, Pierre and Woillard, Jean-Baptiste and Monchaud, Caroline},
  title = {Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0330854}
}
Kostenlos starten →